{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:39:55Z","timestamp":1784194795719,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jiac.2017.08.011","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T16:46:02Z","timestamp":1507740362000},"page":"78-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Mycobacterium abscessus and massiliense lung infection during macrolide treatment for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"24","author":[{"given":"Noriko","family":"Miyake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8804-3181","authenticated-orcid":false,"given":"Yong","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruriko","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuto","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Aono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Takaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Mitarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Shimono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2017.08.011_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2017.08.011_bib2","first-page":"311","article-title":"Infections caused by non-tuberculous mycobacteria in recipients of hematopoietic stem cell transplantation","volume":"4","author":"Al-Anazi","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.jiac.2017.08.011_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.jiac.2017.08.011_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JCM.01327-13","article-title":"Discrimination of Mycobacterium abscessus subsp. massiliense from Mycobacterium abscessus subsp. abscessus in Clinical Isolates by multiplex PCR","volume":"52","author":"Nakanaga","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2017.08.011_bib5","series-title":"Susceptibility testing of mycobacteria, Nocardiae, and other Aerobic Actinomycetes; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2011"},{"key":"10.1016\/j.jiac.2017.08.011_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1348-0421.2010.00221.x","article-title":"Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns","volume":"54","author":"Kim","year":"2010","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jiac.2017.08.011_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/cid\/cit172","article-title":"Mycobacterial genotypes are associated with clinical manifestation and progression of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense","volume":"57","author":"Shin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.08.011_bib8","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1128\/JCM.42.12.5493-5501.2004","article-title":"Amoebal coculture of \u201cMycobacterium massiliense\u201d sp. nov. from the sputum of a patient with hemoptoic pneumonia","volume":"42","author":"Ad\u00e9kambi","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2017.08.011_bib9","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1128\/AAC.40.7.1676","article-title":"Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus","volume":"40","author":"Wallace","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.08.011_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/ciw724","article-title":"Mycobacterial characteristics and treatment outcomes in Mycobacterium abscessus lung disease","volume":"64","author":"Koh","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.08.011_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijantimicag.2013.04.029","article-title":"Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents","volume":"42","author":"Yoshida","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2017.08.011_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/cid\/ciw723","article-title":"Progression and treatment outcomes Of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense","volume":"64","author":"Park","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.08.011_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijantimicag.2010.12.014","article-title":"Comparative in\u00a0vitro and in\u00a0vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium","volume":"37","author":"Sano","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2017.08.011_bib14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12879-016-1689-6","article-title":"Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series","volume":"16","author":"Namkoong","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2017.08.011_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/bmt.2009.106","article-title":"Macrolides in the treatment of bronchiolitis obliterans in allograft recipients","volume":"44","author":"Maimon","year":"2009","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jiac.2017.08.011_bib16","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.bbmt.2016.08.027","article-title":"Azithromycin for the treatment of Obliterative Bronchiolitis after hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"22","author":"Yadav","year":"2016","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.jiac.2017.08.011_bib17","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bbmt.2015.10.009","article-title":"Fluticasone, Azithromycin, and montelukast treatment for new-onset Bronchiolitis Obliterans syndrome after hematopoietic cell transplantation","volume":"22","author":"Williams","year":"2016","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.jiac.2017.08.011_bib18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1182\/blood-2016-08-693507","article-title":"How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"129","author":"Williams","year":"2017","journal-title":"Blood"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17301903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17301903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:57:05Z","timestamp":1761159425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X17301903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1341321X17301903"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2017.08.011","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycobacterium abscessus and massiliense lung infection during macrolide treatment for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2017.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}